Officer and Director Files Intent to Sell $3.84M in Stock, Following $6.13M in Recent Sales

summarizeSummary

An Officer and Director at Apogee Therapeutics has filed to sell $3.84 million in company stock, adding to $6.13 million in sales over the last three months, totaling nearly $10 million in insider dispositions.

check_boxKey Events

• Officer/Director Files Intent to Sell

  Michael Henderson, an Officer and Director, filed a Form 144 to sell 60,000 shares of common stock, valued at approximately $3.84 million.

• Follows Significant Recent Sales

  This proposed sale comes after Henderson sold 80,000 shares for gross proceeds of $6.13 million in the past three months.

• Total Insider Disposition Nears $10 Million

  The combined value of proposed and recent sales by this insider totals approximately $9.97 million.

• Sales Under 10b5-1 Plan

  The sales are being conducted under a Rule 10b5-1 trading plan adopted on August 13, 2025.

auto_awesomeAnalysis

Michael Henderson, an Officer and Director at Apogee Therapeutics, Inc., has filed a Form 144 indicating his intent to sell 60,000 shares of common stock, valued at approximately $3.84 million. This proposed sale follows previous sales by Henderson totaling $6.13 million over the past three months, bringing his total recent and intended sales to nearly $10 million. While the sales are under a pre-planned 10b5-1 program, the cumulative value represents a significant reduction in a key insider's holdings, which could be interpreted negatively by investors.